Eleven new projects to join innovation accelerator scheme

NHS England has named eleven new projects chosen for the latest round of an initiative to develop and spread ideas, equipment and technology that can potentially save lives and money.

Read on PharmaTimes

EU approves post-chemo option for patients with ovarian cancer

European regulators have cleared Tesaro’s Zejula, offering a new option for the maintenance treatment of certain adults with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Read on PharmaTimes

Concordia stands accused of breaching UK competition law

The UK’s Competition and Markets Authority has provisionally ruled that Concordia abused its dominant position to overcharge the NHS by millions of pounds for an essential thyroid drug.

Read on PharmaTimes

US approves ViiV’s two-drug HIV regimen

ViiV Healthcare’s Juluca has been green lighted in the US as the first two-drug regimen for some patients with HIV.

Read on PharmaTimes

Acorda drops experimental Parkinson’s drug

US biotech Acorda Therapeutics is discontinuing development of its experimental Parkinson’s disease therapy tozadenant on concerns over patient safety.

Read on PharmaTimes

1 2 3

Top of page

Industry News

NHS England has named eleven new projects chosen for the latest round of an initiative to develop and spread ideas,...
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us